Antisense Apolipoprotein B-100 As Novel Treatment For Hypercholesterolemia: Focus On Isis 301012
Author:
Affiliation:
1. Academic Medical Center, Department of Vascular Medicine, Meibergdreef 9, F4–159.2, Amsterdam, 1105 AZ, Netherlands Tex.: , Fax.: ,
Publisher
Informa UK Limited
Subject
Biochemistry
Link
https://www.tandfonline.com/doi/pdf/10.2217/17460875.2.4.387
Reference40 articles.
1. Influence of pravastatin and plasma lipids on clinical events in the West of Scotland Coronary Prevention Study (WOSCOPS). Circulation 97, 1440–1445 (1998).
2. Cannon CP, Braunwald E, McCabe CH et al.: Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N. Engl. J. Med. 350, 1495–1504 (2004).
3. Grodos D, Tonglet R: Scandinavian simvastatin study (4S). Lancet 344(8939–8940), 1768 (1994).
4. Nissen SE, Tuzcu EM, Schoenhagen P et al.: Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial. JAMA 291, 1071–1080 (2004).
5. Sacks FM, Pfeffer MA, Moye LA et al.: The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators. N. Engl. J. Med. 335, 1001–1009 (1996).
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Structural insight into antisense gapmer-RNA oligomer duplexes through molecular dynamics simulations;Journal of Biomolecular Structure and Dynamics;2018-11-01
2. Quantum chemical studies of novel 2′-4′ conformationally restricted antisense monomers;International Journal of Quantum Chemistry;2013-06-12
3. Therapeutic potential of antisense oligonucleotides for the management of dyslipidemia;Clinical Lipidology;2011-12-01
4. Short Antisense Oligonucleotides with Novel 2′−4′ Conformationaly Restricted Nucleoside Analogues Show Improved Potency without Increased Toxicity in Animals;Journal of Medicinal Chemistry;2008-12-16
5. Role of lipoprotein lipase in triglyceride metabolism: potential therapeutic target;Future Lipidology;2008-08-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3